JAK Inhibitor Promising for Polymyalgia Rheumatica Oral drug seen as safer than chronic, high-dose steroids Jan 09, 2023
Why Doesn't Exercise Help Everyone With Knee OA? Actually, the better question is why can't everyone do the recommended exercises Jan 04, 2023
Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
Common Treatments for Knee Osteoarthritis May Be Harmful Steroids and NSAIDs reduced pain but not disease course, studies showed Nov 30, 2022
Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
Want a Few Weeks of Knee Pain Relief? Try This Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
Chronic Pain: Opioids No Longer Treatment of Choice Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
New ACR/EULAR Guideline Expands RA Remission Definition Axial spondyloarthritis guidance also gets an update Oct 25, 2022
Does Rheumatoid Arthritis Get Its Start in the Gut? Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
Is PMR the Next Indication for Tocilizumab? Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis But is Russian backing a problem for U.S. approval? Aug 24, 2022
Lubricant Shots for Knee OA: No, They Really Don't Help Meta-analysis of hyaluronic acid trials throws serious shade on common practice Jul 06, 2022
Novel Anti-TNF Shines in Rheumatoid Arthritis Trial Trivalent "nanobody" biologic engineered to accumulate in inflamed tissue Jun 24, 2022
Guideline: Timing Is Everything for RA and Lupus Patients Needing Joint Replacement New advice on which antirheumatic meds to continue and which to stop before surgery Jun 21, 2022
Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritis Phase II results suggest drug could outperform existing agents Jun 03, 2022
Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritis Vindication for clinicians who ignored official recommendations Jun 03, 2022
Air Pollution and Illness: It's Not Just the Lungs and Heart Anymore Expanding range of conditions caused or aggravated by fine particulates Jun 01, 2022
Is Alzheimer's Risk Lower With TNF Inhibitors? For arthritis patients with cardiovascular disease, the answer may be yes Apr 08, 2022
'It's an Alien Knee in There': Mixed Feelings After Joint Replacement Study highlights common, but rarely discussed, problem Mar 28, 2022
Reassurance on Steroid Shots for Knee OA Study counters fears that injections worsen underlying pathology Mar 17, 2022
Ankylosing Spondylitis: Another Step Toward Individualized Therapy Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
Hopes Dashed for Novel Osteoarthritis Treatment Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
Mystery: Why Would Hand OA Be Less Severe in Black People? Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
Muddled Picture for Antidepressant as Osteoarthritis Pain Reliever Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
Another Trial, Another PRP Flop in Osteoarthritis Fails to outperform saline in randomized trial Nov 23, 2021
Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
